Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INSMED Inc Director's Dealing 2025

May 22, 2025

30150_dirs_2025-05-22_1d6291d3-ac6b-4b9a-9660-9d35dfb7454b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-05-20

Reporting Person: Desjardins Clarissa (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-05-20 Common Stock P 1895 $66.87 Acquired 1895 Indirect
2025-05-21 Common Stock P 1130 $66.35 Acquired 3025 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 67007 Direct

Footnotes

F1: This is the weighted average purchase price representing 1,895 shares purchased at prices ranging from $66.75 to $66.98 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request.